Showing results (71-80 of 114) with videos related to
Sort By:
Pageof 12
The American Journal of Surgical Pathology|February 15, 2011
Sequential development of histiocytic sarcoma and diffuse large b-cell lymphoma in a patient with a remote history of follicular lymphoma with genotypic evidence of a clonal relationship: a divergent (bilineal) neoplastic transformation of an indolent B-cell lymphoma in a single individualEndi Wang, John Papalas, Charles Blake Hutchinson, et al.Cancer Letters|July 25, 2022
PPAR agonists attenuate lenalidomide's anti-myeloma activity in vitro and in vivoYonggang Sha, Jian Wu, Barry Paul, et al.American Journal of Clinical Pathology|July 12, 2018
Chronic Myeloid Leukemia Following Treatment for Primary Neoplasms or Other Medical ConditionsLian-He Yang, Pu Su, Catherine Luedke, et al.Pathology, Research and Practice|November 9, 2019
Sequential development of human herpes virus 8-positive diffuse large B-cell lymphoma and chronic myelomonocytic leukemia in a 59 year old female patient with hemoglobin SC diseaseYue Zhao, Jake Maule, Yang Li, et al.Archives of Pathology & Laboratory Medicine|April 3, 2013
Diagnostic and clinical considerations in concomitant bone marrow involvement by plasma cell myeloma and chronic lymphocytic leukemia/monoclonal B-cell lymphocytosis: a series of 15 cases and review of literatureChristopher L Alley, Endi Wang, Cherie H Dunphy, et al.Cancer Medicine|July 7, 2020
The impact of bone marrow fibrosis and JAK2 expression on clinical outcomes in patients with newly diagnosed multiple myeloma treated with immunomodulatory agents and/or proteasome inhibitorsBarry Paul, Yue Zhao, Gavin Loitsch, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 13, 2018
CD3-positive plasmablastic B-cell neoplasms: a diagnostic pitfallZenggang Pan, Mingyi Chen, Qianyun Zhang, et al.American Journal of Clinical Pathology|March 13, 2014
p53 expression is a strong marker of inferior survival in de novo diffuse large B-cell lymphoma and may have enhanced negative effect with MYC coexpression: a single institutional clinicopathologic studyYi Xie, Mohmad Ajaz Bulbul, Lingyun Ji, et al.Journal of Clinical Pathology|February 5, 2021
Myeloid neoplasms in the setting of chronic lymphocytic leukaemia/chronic lymphocytic leukaemia-like disease: a clinicopathological study of 66 cases comparing cases with prior history of treatment to those withoutCatherine Luedke, Yue Zhao, Jenna McCracken, et al.Human Pathology|December 9, 2017
Composite lymphoma of follicular B-cell and peripheral T-cell types with distinct zone distribution in a 75-year-old male patient: a case studyJohn Tanaka, Pu Su, Catherine Luedke, et al.Pageof 12